RULES WERE NOT MEANT FOR THIS BMW. There's a reason the 2 Series is so loved. Blisteringly fast, the 335-horsepower rear-wheel drive M240i Coupe sprints from 0 to 60 mph in just 4.4 seconds, or 4.2 seconds with xDrive, and handles with a steering agility and control that are incredibly precise.
Tecentriq was approved by the U.S. Food and Drug Administration (FDA) for some patients with lung cancer. PUBLISHED: OCTOBER 18, 2016. Be the first to discuss this article on CURE's forum.
The Food and Drug Administration (FDA) on May 18 approved atezolizumab (TecentriqÂ®) for the treatment of some patients with urothelial carcinoma, the most common type of bladder cancer. The drug, which strengthens the bodyâs immune response against cancer, is the first new treatment approved for bladder cancer in two decades.